Abstract
MICs of Bay 12-8039 and comparative antimicrobials were determined for 820 recent clinical isolates. Ciprofloxacin was approximately 2-fold more active than Bay 12-8039 and ofloxacin against Enterobacteriaceae and approximately 8-fold more active against Pseudomonas aeruginosa. Bay 12-8039 was approximately 2- to 16-fold more active than ciproiloxacin and ofloxacin against nonfermenters (except P. aeruginosa), staphylococci, streptococci, enterococci, and anaerobes. As determined by regression analysis, there was a high degree of correlation among quinolone MICs.
Full Text
The Full Text of this article is available as a PDF (192.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barry A. L., Fuchs P. C. Cross-resistance and cross-susceptibility between fluoroquinolone agents. Eur J Clin Microbiol Infect Dis. 1991 Dec;10(12):1013–1018. doi: 10.1007/BF01984922. [DOI] [PubMed] [Google Scholar]
- Fass R. J., Barnishan J., Solomon M. C., Ayers L. W. In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli. Antimicrob Agents Chemother. 1996 Jun;40(6):1412–1418. doi: 10.1128/aac.40.6.1412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fass R. J. In vitro activity of Bay y 3118, a new quinolone. Antimicrob Agents Chemother. 1993 Nov;37(11):2348–2357. doi: 10.1128/aac.37.11.2348. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fass R. J. In vitro activity of ciprofloxacin (Bay o 9867). Antimicrob Agents Chemother. 1983 Oct;24(4):568–574. doi: 10.1128/aac.24.4.568. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fass R. J. Use of frequency distribution curves, scattergrams and regression analyses to compare in vitro activities and describe cross-susceptibility and cross-resistance among four quinolones. J Chemother. 1994 Dec;6(6):368–376. doi: 10.1080/1120009x.1994.11736491. [DOI] [PubMed] [Google Scholar]
- King A., Bethune L., Phillips I. The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin. J Antimicrob Chemother. 1991 Nov;28(5):719–725. doi: 10.1093/jac/28.5.719. [DOI] [PubMed] [Google Scholar]
- Thomson K. S., Sanders C. C., Hayden M. E. In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises. Antimicrob Agents Chemother. 1991 Nov;35(11):2329–2334. doi: 10.1128/aac.35.11.2329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Woodcock J. M., Andrews J. M., Boswell F. J., Brenwald N. P., Wise R. In vitro activity of BAY 12-8039, a new fluoroquinolone. Antimicrob Agents Chemother. 1997 Jan;41(1):101–106. doi: 10.1128/aac.41.1.101. [DOI] [PMC free article] [PubMed] [Google Scholar]